Understanding Liver Transplant Injury with Advanced Data Analysis
Computational Core: Biostatistical Analysis and Network Modelling
This core provides advanced data analysis and modeling tools to help researchers understand how the immune system reacts to liver transplant injury.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11176127 on NIH RePORTER |
What this research studies
This project provides essential data management and statistical support for a larger research effort focused on liver transplant injury. Researchers use these tools to organize complex data, analyze immune responses, and create models that help predict outcomes. This work is crucial for integrating findings from different parts of the overall research, including studies involving human liver transplants. By processing vast amounts of information, this core helps uncover new insights into how the body responds to a new liver.
Who could benefit from this research
Good fit: Patients who have received or are awaiting a liver transplant, particularly those experiencing or at risk for ischemia/reperfusion injury, could ultimately benefit from the insights gained.
Not a fit: Patients without liver transplant-related conditions or those not affected by ischemia/reperfusion injury would not directly benefit from this specific research core.
Why it matters
Potential benefit: If successful, this work could lead to a deeper understanding of liver transplant complications, potentially improving patient outcomes and guiding new treatment strategies.
How similar studies have performed: Computational and biostatistical cores are standard components of large-scale biomedical research projects, and their methodologies are well-established for analyzing complex biological data.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Gjertson, David — University of California Los Angeles
- Study coordinator: Gjertson, David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.